)
Visual24 Oct 2025
The rise of Alphabet
Bioxytran (BIXT) investor relations material
Bioxytran Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary11 Aug, 2025
Executive summary
Remains a clinical-stage pharmaceutical company focused on developing therapeutics for hypoxia and viral diseases, with no product revenue as of June 30, 2025.
Completed recruitment for a Phase 1b/2a COVID-19 trial in India; results expected within 90 days, with a Phase 3 trial contingent on positive outcomes.
U.S. FDA-approved IND for a COVID-19 trial, with initiation planned for Q3 2025; additional INDs for COVID-19 and lung fibrosis treatments in India also expected to start in Q3 2025.
Animal testing of BXT-25 acellular oxygen carrier showed non-toxicity and full recovery in mice; further preclinical studies planned.
Financial highlights
Net loss for the six months ended June 30, 2025, was $1,318,197, compared to $1,222,169 for the same period in 2024.
Net profit of $35,437 for the three months ended June 30, 2025, versus a net loss of $661,647 for the same quarter last year, driven by a reduction in derivative liability.
Accumulated deficit increased to $20,239,366 as of June 30, 2025, from $18,921,169 at December 31, 2024.
Cash balance was $3,144 at June 30, 2025, down from $5,154 at year-end 2024.
Negative working capital of $2,779,627 at June 30, 2025, compared to negative $1,925,488 at December 31, 2024.
Outlook and guidance
Management estimates at least $3.7 million in new funding is needed to support operations and development for the next 15 months.
Plans to raise $2 million via a private placement in spring 2025; ongoing efforts to secure additional capital.
Without additional funding, may need to extend payables, reduce overhead, or scale back business plans.
Assess impact of stock price on derivative liability.
Explain the payroll forfeiture by management.
When is the ProLectin-M trial expected to start?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Bioxytran earnings date
Q3 202511 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Bioxytran Inc. is a biotechnology company focused on developing therapies for fibrotic and viral diseases. The company specializes in glycovirology, using carbohydrate-based drugs to target viral infections and inflammatory conditions. Its research includes treatments for diseases such as COVID-19 and pulmonary fibrosis, aiming to improve oxygen delivery and tissue regeneration. The company is headquartered in Needham, Massachusetts, and its shares are listed on the OTCQB.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage